Our data demonstrate that G3 patients are characterized by a strong PD-L1 expression in both tumor and infiltrating immune cells (P<0.001; Table 2), reflecting an unfavorable environment for T-cell-mediated tumor aggression. The gene discussed is CD274; the disease is neoplasm.